Additional treatment with clarithromycin reduces fever duration in patients with influenza
- 1 September 2014
- journal article
- research article
- Published by Elsevier in Respiratory Investigation
- Vol. 52 (5) , 302-309
Abstract
No abstract availableKeywords
Funding Information
- Abbott-Japan Co., Ltd.
- Taisho Toyama Pharmaceutical Co., Ltd.
This publication has 24 references indexed in Scilit:
- Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is lifeJournal of Antimicrobial Chemotherapy, 2011
- An epidemiological analysis of severe cases of the influenza A (H1N1) 2009 virus infection in JapanInfluenza and Other Respiratory Viruses, 2010
- Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoNew England Journal of Medicine, 2009
- Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patientsThe Journal of Pathology, 2008
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control studyThorax, 2003
- Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responsesJournal of Medical Virology, 2001
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.Journal of Clinical Investigation, 1998